Sergi Sanz Bravo

Biostatistic, Head of Unit

Barcelona Institute for Global Health

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Imaging Medical Imaging professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sergi Sanz Bravo is a Biostatistician and Head of Unit at the Barcelona Institute for Global Health in Spain. His research focuses on the diagnosis and treatment of infectious diseases, particularly tuberculosis and malaria in vulnerable populations, as evidenced by his recent work on rapid diagnostic assays and clinical trials. He has made significant contributions to the understanding of Chagas disease and its classification, advocating for improved diagnostic methods and treatment protocols.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (6)

Helen Cox

Burnet Institute

AUSTRALIA

View details

Heimo Lagler

Associate Professor

Medical University of Vienna

AUSTRIA

View details

Myriam El Gaaloul

Head o Clinical Sciences & Regulatory

Medicines for Malaria Venture

SWITZERLAND

View details

Michael Ramharter

Professor

Bernhard-Nocht-Institut für Tropenmedizin

GERMANY

View details

ANDREA VERGARA

Associated professor

University of Barcelona

SPAIN

View details

Mark Nicol

University of Western Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sergi Sanz Bravo

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.

Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens

Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)

Reply to Paranhos-Baccalà et al. Comment on “Cuesta et al. An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis. <i>Diagnostics</i> 2024, <i>14</i>, 802”

An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis

A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation

Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial

Evaluation and validation of a PrintrLab-based LAMP assay to identify Trypanosoma cruzi in newborns in Bolivia: a proof-of-concept study

How do we classify organ involvement in Chagas disease? A systematic review of organ involvement since 1909, Highlighting the urgent need for a universal classification system in Chronic Chagas disease

Five-year serological and clinical evolution of chronic Chagas disease patients in Cochabamba, Bolivia

Collaborators (6)

Helen Cox

Heimo Lagler

Myriam El Gaaloul

Michael Ramharter

ANDREA VERGARA

Mark Nicol

Make your next move.